Log in
Enquire now
Attune Pharmaceuticals, Inc

Attune Pharmaceuticals, Inc

Attune Pharmaceuticals, Inc is an oral small molecules for rare diseases.

OverviewStructured DataIssuesContributors

Contents

attunepharma.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biopharmaceutical
Biopharmaceutical
Biotechnology
Biotechnology
Biology
Biology
Technology
Technology
Pharmaceutical industry
Pharmaceutical industry
Location
New York City
New York City
0
New York
New York
CEO
‌
Andrew McDonald (entrepreneur)
0
Pitchbook URL
pitchbook.com/profiles...169345-27
Number of Employees (Ranges)
1 – 100
Email Address
info@attunepharma.com0
Full Address
250 West 55th Street, 34th Floor New York, NY 100190
Investors
Tavistock Group
Tavistock Group
0
Venrock
Venrock
0
LifeSci Venture Partners
LifeSci Venture Partners
0
‌
Tang Capital
0
Boxer Capital
Boxer Capital
0
RTW Investments LLC
RTW Investments LLC
0
RA Capital Management
RA Capital Management
Total Funding Amount (USD)
23,000,000
Latest Funding Round Date
January 2019
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
3
Country
United States
United States
0
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Attune Pharmaceuticals, Inc

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.